| 000 | 01217 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513153744.0 | ||
| 264 | 0 | _c19981110 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(05)70524-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohl, W | |
| 245 | 0 | 0 |
_aCoronary stenting and use of abciximab. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cOct 1998 |
||
| 300 |
_a1312 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter; Comment | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAngioplasty, Balloon |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 700 | 1 | _aMenges, M | |
| 700 | 1 | _aHennen, B | |
| 700 | 1 | _aSchieffer, H | |
| 700 | 1 | _aZeitz, M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 352 _gno. 9136 _gp. 1312 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(05)70524-9 _zAvailable from publisher's website |
| 999 |
_c9753005 _d9753005 |
||